Is oral ketotifen available in the USA?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Availability of Oral Ketotifen in the USA

Oral ketotifen is not available in the United States, though it is available in other countries around the world. 1

Current Status in the USA

Ketotifen is only available in the United States as an ophthalmic (eye drop) formulation, marketed under brand names such as Alaway and Zaditor for the treatment of allergic conjunctivitis. 1 The ophthalmic formulation is classified as a dual-action agent with both antihistamine and mast cell stabilizing properties.

Available Formulations in the USA

  • Ophthalmic solution: Ketotifen fumarate 0.025% is FDA-approved and available over-the-counter for the temporary relief of itching due to allergic conjunctivitis 1, 2
  • Oral formulation: Not available in the United States 1

International Availability

Oral ketotifen is available in many countries outside the United States for the treatment of:

  • Allergic disorders
  • Bronchial asthma
  • Atopic dermatitis
  • Seasonal or perennial rhinitis
  • Allergic conjunctivitis
  • Chronic or acute urticaria
  • Food allergy 3

Clinical Efficacy of Available Ketotifen Products

The ophthalmic formulation of ketotifen available in the USA:

  • Has a rapid onset of action (within 15 minutes)
  • Provides extended duration of action (at least 8 hours)
  • Effectively reduces ocular itching and hyperemia associated with allergic conjunctivitis 2
  • Is safe and well-tolerated in both adult and pediatric populations 4, 5

Alternative Medications Available in the USA

For patients seeking oral medications with similar properties to ketotifen, the following alternatives are available in the USA:

  1. Cyproheptadine: A first-generation antihistamine with similar dual function as both an H1 antihistamine and serotonin receptor antagonist. It can be used to treat dermatologic, gastrointestinal, and neuropsychiatric symptoms. 1, 6

  2. Other oral antihistamines: For allergic conditions, various oral antihistamines are available in the USA, though they may not have the same mast cell stabilizing properties as ketotifen. 1

Important Considerations

If you are seeking an oral medication with similar properties to ketotifen for allergic conditions, consult with your healthcare provider about appropriate alternatives available in the United States. The specific alternative recommended will depend on your condition and symptoms.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2004

Guideline

Cyproheptadine Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.